Quotient Sciences won the Outstanding Achievement Award at the 2019 Medilink UK Healthcare Business Awards.
The Medilink UK Healthcare Business Awards recognize organizations that have made significant contributions to life sciences and who have excelled in their categories across the healthcare industry. Winners were chosen from an exclusive shortlist comprised entirely of winners from each of the regional Medilink awards.
The Outstanding Achievement Award recognizes the Company's momentous success and continued development. Quotient Sciences has experienced significant growth and global expansion following a series of acquisitions and facility investments in the U.K. and the U.S. and now employs over 850 employees across six operating sites.
Mark Egerton, CEO of Quotient Sciences said, “We are delighted to have won the Outstanding Achievement award. It is a great recognition for all the hard work and continuous commitment and dedication of our staff. Well done to the team for delivering this success."
Quotient Sciences was also recognized for its innovative approach to drug development, Translational Pharmaceutics®, which enables significant shortening of drug development times and reduced costs for biotechnology and pharmaceutical clients throughout the world.